About AGA
About AGA
AGA Corporate Roundtable
The AGA Corporate Roundtable engages corporate partners and AGA leadership in dialogue regarding innovations in practice, clinical and research advances, public policy, and other issues that impact the future of gastroenterology and hepatology care. Our goal is to work together to better serve the GI community and improve care for digestive disease patients.
2023-2024 AGA Corporate Roundtable Members
GOLD SUPPORTERS
AbbVie
Bristol Myers Squibb
Eli Lilly and Company
Ferring Pharmaceuticals
Pfizer, Inc.
Salix Pharmaceuticals
Takeda Pharmaceuticals U.S.A., Inc.
SILVER SUPPORTERS
Amgen
Boston Scientific
Exact Sciences
Genentech, Inc
Geneoscopy, Inc.
Janssen Biotech, Inc.
Novo Nordisk
Phathom Pharmaceuticals Inc.
Sandoz, Inc (A Novartis Division)
As of July 24, 2023
AGA Corporate Roundtable membership information
Membership to the corporate roundtable supports the AGA Research Foundation. Benefits of participation in the roundtable include:
- Access to AGA leadership and other industry leaders.
- Up to date information on the latest news in the field.
- Opportunity to share your insights and opinions.
- Visibility at DDW events.
- Recognition in AGA communications including journals, website and newsletters